BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

BASF Received Excipact™ Certification As Pharmaceutical Excipient Supplier


1/8/2014 9:10:38 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Brussels, Belgium / Ludwigshafen, Germany – January 8, 2014 – BASF has received the EXCiPACT™ Certificate for pharmaceutical excipients for the group of polyvinylpyrrolidone (Kollidon®) polymers, produced in Ludwigshafen. The certificate was issued by mdc medical device certification GmbH - one of EXCiPACT’s internationally-recognized Certification Bodies.

The certification demonstrates that BASF manufactures and distributes pharmaceutical excipients according to the EXCiPACT Good Manufacturing Practices (GMP). “With the certificate we confirm that our customers only get the highest quality excipients,” said Fran?ois Scheffler, Vice President Global Marketing at BASF Pharma Ingredients & Services business unit. “With our Kollidon portfolio we ensure to achieve the highest standards in regulatory, quality and safety.” BASF will conduct recertification audits every three years, plus annual surveillance audits to ensure the continued safety and quality of excipients.

The EXCiPACT scheme can be made available when the regulators in the EU and USA require the holder of the marketing authorization for medicines to ensure that appropriate GMP and GDP is applied to the manufacture and distribution of both APIs and excipients. The US Food and Drug Administration and the European Medicines Agency continue to require drug producers to qualify their excipient suppliers appropriately and, as a result the suppliers must be prepared to receive increasing numbers of audits from their customers. EXCiPACT helps to avoid additional audits in a cost-effective manner for all parties concerned because one single audit will be all it takes to prove an excipient complies with current GMP and GDP requirements. “BASF is the third company which has been certified by EXCiPACT,” said Dr. Iain Moore, Chairman of the EXCiPACT Association’s Global Steering Committee. “With the certificate we minimize risks for customers and help ensure patient safety while reducing costs.”

About EXCiPACT

EXCiPACT is a project of the IPEC Federation, a global organization to promote quality in pharmaceutical excipients (see www.ipecfed.org ). EXCiPACT is a voluntary international scheme to provide for independent 3rd party certification of manufacturers, suppliers and distributors of pharmaceutical excipients worldwide. It will ensure patient safety through supplier quality while minimizing the overall costs for assessing the excipient supply chain. It was launched in January 2012 since when there has been considerable interest among pharmaceutical excipient suppliers, customers and regulators. For further information see www.excipact.org or contact info@excipact.org.

About BASF

BASF is the world’s leading chemical company: The Chemical Company. Its portfolio ranges from chemicals, plastics, performance products and crop protection products to oil and gas. We combine economic success with environmental protection and social responsibility. Through science and innovation, we enable our customers in nearly every industry to meet the current and future needs of society. Our products and solutions contribute to conserving resources, ensuring nutrition and improving quality of life. We have summed up this contribution in our corporate purpose: We create chemistry for a sustainable future. BASF had sales of €72.1 billion in 2012 and more than 110,000 employees as of the end of the year. BASF shares are traded on the stock exchanges in Frankfurt (BAS), London (BFA) and Zurich (AN). Further information on BASF is available on the Internet at www.basf.com.

Contact:
Carole Capitaine
EXCiPACT
Office
info@excipact.org
+32 2 736 53 54
Nina Osten
BASF SE
Global Communications Nutrition & Health
nina.osten@basf.com
+49 621 60 48978

Help employers find you! Check out all the jobs and post your resume.


Read at BioSpace.com

BASF
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES